MX2010008875A - Agonistas nicotinicos alfa 7 y antipsicoticos. - Google Patents

Agonistas nicotinicos alfa 7 y antipsicoticos.

Info

Publication number
MX2010008875A
MX2010008875A MX2010008875A MX2010008875A MX2010008875A MX 2010008875 A MX2010008875 A MX 2010008875A MX 2010008875 A MX2010008875 A MX 2010008875A MX 2010008875 A MX2010008875 A MX 2010008875A MX 2010008875 A MX2010008875 A MX 2010008875A
Authority
MX
Mexico
Prior art keywords
combination
antipsychotics
alpha
nicotinic agonists
nicotinic
Prior art date
Application number
MX2010008875A
Other languages
English (en)
Inventor
Merouane Bencherif
Gregory J Gatto
Kristen G Jordan
Terry Hauser
Sharon R Letchworth
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Publication of MX2010008875A publication Critical patent/MX2010008875A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a una combinación sinergística de un agonista nicotínico alfa7 (a7) y un agente antipsicótico.
MX2010008875A 2008-02-13 2009-02-13 Agonistas nicotinicos alfa 7 y antipsicoticos. MX2010008875A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2828208P 2008-02-13 2008-02-13
PCT/US2009/034062 WO2009102962A2 (en) 2008-02-13 2009-02-13 Combination of alpha 7 nicotinic agonists and antipsychotics

Publications (1)

Publication Number Publication Date
MX2010008875A true MX2010008875A (es) 2010-08-31

Family

ID=40902222

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008875A MX2010008875A (es) 2008-02-13 2009-02-13 Agonistas nicotinicos alfa 7 y antipsicoticos.

Country Status (26)

Country Link
US (1) US20110059947A1 (es)
EP (2) EP2254598B1 (es)
JP (1) JP2011511845A (es)
KR (1) KR20100113163A (es)
CN (2) CN101977628A (es)
AU (1) AU2009214625A1 (es)
BR (1) BRPI0907570A2 (es)
CA (1) CA2715268A1 (es)
CO (1) CO6290706A2 (es)
CY (1) CY1114492T1 (es)
DK (1) DK2254598T3 (es)
EC (1) ECSP10010471A (es)
ES (1) ES2430622T3 (es)
HK (1) HK1147954A1 (es)
HR (1) HRP20130749T1 (es)
IL (1) IL207389A0 (es)
MX (1) MX2010008875A (es)
NZ (1) NZ587312A (es)
PL (1) PL2254598T3 (es)
PT (1) PT2254598E (es)
RS (1) RS52941B (es)
RU (1) RU2481123C2 (es)
SG (1) SG188144A1 (es)
SI (1) SI2254598T1 (es)
WO (1) WO2009102962A2 (es)
ZA (1) ZA201005999B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
SA08290475B1 (ar) * 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
WO2012040404A1 (en) 2010-09-23 2012-03-29 Abbott Laboratories Monohydrate of an azaadamantane derivative
BR112013018296A2 (pt) * 2011-01-18 2016-11-16 Targacept Inc tratamento de disfunções cognitivas em esquizofrenia
EP2704573A4 (en) * 2011-05-03 2014-10-15 Merck Sharp & Dohme AMINOMETHYL biaryl BENZOTRIAZOL DERIVATIVES
CA2886010A1 (en) * 2012-10-02 2014-04-10 Sumitomo Dainippon Pharma Co., Ltd. Imidazole derivative
BR112019012573A2 (pt) 2016-12-20 2019-11-19 Lts Lohmann Therapie Systeme Ag sistema terapêutico transdérmico que contém asenapina e polissiloxano ou poli-isobutileno
WO2018115001A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN108727416B (zh) * 2017-04-20 2021-03-09 北京大学 三环杂芳香体系酰胺衍生物及其制备和用途
ES2881783T3 (es) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona
CN107469087A (zh) * 2017-09-10 2017-12-15 孙永丽 用于治疗精神病的制剂
CN112704672A (zh) 2018-06-20 2021-04-27 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
JP2024502470A (ja) * 2021-01-08 2024-01-19 アイエフエム デュー インコーポレイテッド Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物
DE102022114269A1 (de) 2022-06-07 2023-12-07 Rational Aktiengesellschaft Gargerät mit einem Selbstreinigungssystem sowie ein Verfahren zum Ändern von Reinigungsparametern für das Gargerät

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597919A (en) 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5712270A (en) 1995-11-06 1998-01-27 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
US5616716A (en) * 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
US5663356A (en) 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
CA2333951C (en) 1998-06-01 2012-02-28 Ortho-Mcneil Pharmaceutical, Inc. Method for treating neurodegenerative disorders
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
SE9904176D0 (sv) 1999-11-18 1999-11-18 Astra Ab New use
NZ519381A (en) * 1999-12-10 2004-04-30 Wyeth Corp New therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
TR200400420T4 (tr) * 2000-06-27 2004-03-22 Laboratorios S.A.L.V.A.T., S.A. Arilalkilaminlerden türetilmiş karbamatlar.
WO2002016358A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
AU2001284645A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
AU2001282910A1 (en) 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands
AU2001284646A1 (en) 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6500840B2 (en) 2000-08-21 2002-12-31 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6554086B1 (en) * 2000-10-27 2003-04-29 Invacare Corporation Obstacle traversing wheelchair
PE20020719A1 (es) 2000-12-22 2002-10-11 Almirall Prodesfarma Ag Derivados de carbamato de quinuclidina como agentes antimuscarinicos m3
EP1476448A2 (en) * 2002-02-19 2004-11-17 PHARMACIA & UPJOHN COMPANY Azabicyclic compounds for the treatment of disease
PL377052A1 (pl) * 2002-12-06 2006-01-23 Pharmacia & Upjohn Company Llc Krystaliczne fumarany 1-azabicyklo [2,2,2] oktylofuro [2,3-c] pirydynylokarboksyamidu oraz ich kompozycje i preparaty
TW200502222A (en) * 2003-04-02 2005-01-16 Novartis Ag Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2004099202A1 (en) * 2003-05-05 2004-11-18 Pharmacia & Upjohn Company Llc Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases
US7309699B2 (en) * 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
JP2007516275A (ja) * 2003-12-23 2007-06-21 ファイザー・プロダクツ・インク 認知増強および精神病性障害のための治療的組合せ
EP1863485A2 (en) * 2005-03-18 2007-12-12 Abbott Laboratories Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions

Also Published As

Publication number Publication date
HK1147954A1 (en) 2011-08-26
SI2254598T1 (sl) 2013-10-30
NZ587312A (en) 2011-12-22
ECSP10010471A (es) 2010-10-30
AU2009214625A1 (en) 2009-08-20
BRPI0907570A2 (pt) 2019-09-24
EP2254598A2 (en) 2010-12-01
HRP20130749T1 (en) 2013-10-11
KR20100113163A (ko) 2010-10-20
CN103143023A (zh) 2013-06-12
CN101977628A (zh) 2011-02-16
CA2715268A1 (en) 2009-08-20
PT2254598E (pt) 2013-10-16
WO2009102962A2 (en) 2009-08-20
SG188144A1 (en) 2013-03-28
RU2481123C2 (ru) 2013-05-10
EP2254598B1 (en) 2013-07-10
RS52941B (en) 2014-02-28
WO2009102962A3 (en) 2009-10-08
IL207389A0 (en) 2010-12-30
JP2011511845A (ja) 2011-04-14
ZA201005999B (en) 2011-05-25
RU2010137787A (ru) 2012-03-20
CY1114492T1 (el) 2016-10-05
CO6290706A2 (es) 2011-06-20
DK2254598T3 (da) 2013-07-29
PL2254598T3 (pl) 2013-12-31
EP2633868A1 (en) 2013-09-04
ES2430622T3 (es) 2013-11-21
US20110059947A1 (en) 2011-03-10

Similar Documents

Publication Publication Date Title
MX2010008875A (es) Agonistas nicotinicos alfa 7 y antipsicoticos.
IL254406B (en) Guanylate cyclase agonists, preparations containing them and their uses
IL262838A (en) Guanylate cyclase agonists for use in the treatment of hypercholesterolemia
ZA201103044B (en) Conjugates of glp-1 agonists and uses thereof
HRP20130713T1 (en) Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
PL2252671T3 (pl) Podobna do azeotropu kompozycja 1,1,1-trifluoro-3-chloropropenu i dimetoksymetanu
SG171584A1 (en) Nanoparticulate metal boride composition and its use for identification- marking plastic parts
TN2011000040A1 (en) Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists
MY156511A (en) Compositions and devices
TWI372757B (en) Ep2 agonists
ZA200809941B (en) 2-anilino-4-(heterocyclic)amino-pyrimidines
ZA200806392B (en) Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as SIP receptor agonists
TN2012000002A1 (en) Gpr119 agonists
IL212364A0 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
IL210773A0 (en) Neuropeptide-2 receptor (y-2r) agonists and uses thereof
MX2009013982A (es) Composiciones que comprenden inhibidores de triptofano hidroxilasa.
EP1971671A4 (en) LUBRICANT COMPOSITION WITH IMPROVED SOLUTION ASSETS
IL215049A0 (en) Gpr119 agonist compound, compositions comprising the same and uses thereof
ZA201001252B (en) Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
EP2239313A4 (en) LUBRICANT COMPOSITION AND MECHANICAL ELEMENT
EP2091957A4 (en) HYDROGEN CLEAVAGE COMPOSITION
DK1987121T3 (da) Biocid hydrogenperoxidsammensætning med forøget aktivitet
JO2730B1 (en) Medications for the treatment of endometriosis
ZA201104160B (en) Crhr2 peptide agonists and uses thereof
ZA200805203B (en) Lubricant composition with improved solvency

Legal Events

Date Code Title Description
FA Abandonment or withdrawal